Healthy lifestyle. Maltreatment NOS
Conditions
Interventions
Intervention 1: Control group: the content of this group included the recommendations and information in terms of change healthy lifestyle and adherence to treatment that conducted by a health center
Lifestyle
Control group: the content of this group included the recommendations and information in terms of change healthy lifestyle and adherence to treatment that conducted by a health center staff using a le
Motivational interviewing group: the intervention was done through a psychologist who was authorized, each group ranged from 7 to 10 subjects that trained for 6 sessions over six months (45 to 60 minu
Sponsors
Golestan University of Medical Science (Technology and Information Department)
Eligibility
Sex/Gender
All
Age
18 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria were as follows: 1) patients diagnosed with hypertension by a physician; 2) patients who received one antihypertensive medication at least; 3) patients who agreed to participate in the survey and more than 18 years old. Excluded criteria were as: 1) pregnant women and being pregnant during the study and 2) secondary hypertensive patients.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The laboratory and clinical indices (systolic blood pressure, the diastolic blood pressure, triglyceride level and total cholesterol, the symptoms of hypertension, and the complications of hypertension). Timepoint: Baseline (pre-test). Method of measurement: Laboratory and clinical sheet.;Blood pressure. Timepoint: Baseline (pre-test). Method of measurement: Blood test, when patient in sitting position, 5 minutes after sitting from the left arm.;Treatment Adherence. Timepoint: Baseline (pre-test). Method of measurement: Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH).;Demographic status (included age, gender, marital status, educational level and diagnosis duration). Timepoint: Baseline (pre-test). Method of measurement: Demographic questionnaire.;Self-efficacy. Timepoint: Baseline (pre-test). Method of measurement: General Self-Efficacy Scale (GSES).;Quality of life. Timepoint: Baseline (pre-test). Method of measurement: Medical outcomes study 36- item short form (SF-36). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Follow-up after 6 month. Method of measurement: Medical outcomes study 36- item short form (SF-36).;Self-efficacy. Timepoint: Follow-up after 6 month. Method of measurement: General Self-Efficacy Scale (GSES).;Treatment Adherence. Timepoint: Follow-up after 6 month. Method of measurement: Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH).;The laboratory and clinical indices (systolic blood pressure, the diastolic blood pressure, triglyceride level and total cholesterol, the symptoms of hypertension, and the complications of hypertension(. Timepoint: Follow-up after 6 month. Method of measurement: Laboratory and clinical sheet.;Blood pressure. Timepoint: Follow-up after 6 month. Method of measurement: Blood test, when patient in sitting position, 5 minutes after sitting from the left arm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyyed Kamal Mirkarimi
Golestan University of Medical Science
Outcome results
None listed